Harel Insurance Investments & Financial Services’s DarioHealth DRIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-20
Closed -$1K 625
2023
Q3
$1K Sell
20
-4
-17% -$269 ﹤0.01% 647
2023
Q2
$2K Sell
24
-13
-35% -$987 ﹤0.01% 677
2023
Q1
$3K Buy
37
+16
+76% +$1.57K ﹤0.01% 686
2022
Q4
$2K Sell
21
-1
-5% -$90 ﹤0.01% 667
2022
Q3
$2K Sell
22
-1
-4% -$107 ﹤0.01% 685
2022
Q2
$3K Sell
23
-1
-4% -$117 ﹤0.01% 693
2022
Q1
$3K Buy
24
+4
+20% +$662 ﹤0.01% 677
2021
Q4
$5K Sell
20
-10
-33% -$3.04K ﹤0.01% 703
2021
Q3
$8K Buy
30
+3
+11% +$866 ﹤0.01% 640
2021
Q2
$11K Buy
+27
New +$10.3K ﹤0.01% 744

Other funds holding DRIO

Harel Insurance Investments & Financial Services's DRIO Position: Q4 2023 in Review

Harel Insurance Investments & Financial Services sold out of DarioHealth (DRIO) in Q4 2023, closing a stake of 20 shares — an estimated $1K sold.

Harel Insurance Investments & Financial Services first reported a position in DRIO in Q2 2021 and held it in 10 quarters. The position peaked at $11K in Q2 2021. 35 funds tracked by Wall St. Rank hold DRIO as of Q4 2023.

  • Harel Insurance Investments & Financial Services reported no remaining DarioHealth position as of Q4 2023 after selling out during the quarter.
  • Harel Insurance Investments & Financial Services sold 20 DarioHealth shares in Q4 2023, an estimated $1K.
  • Harel Insurance Investments & Financial Services first reported a position in DarioHealth in Q2 2021 and held it in 10 quarters.
  • Harel Insurance Investments & Financial Services's DarioHealth position peaked at $11K in Q2 2021.
  • 35 funds tracked by Wall St. Rank held DarioHealth as of Q4 2023.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q4 2023, filed 30 Jan 2024.